Funded Startups in Linköping
In Linköping, the largest disclosed round in the 7 most recent entries is SweGaN’s $13M Series B (2024-09-18).
In Linköping, the largest disclosed round in the 7 most recent entries is SweGaN’s $13M Series B (2024-09-18). That amount dwarfs the rest of the disclosed figures, including the next-largest $3M rounds for ArgusEye (2024-05-13) and Lurkit (2022-06-09), while all other disclosed rounds sit at $6M or below (with several below $1M: RemaSawco $150K on 2022-10-10 and Medius $100K on 2022-03-16).
The dates also cluster: three rounds fall between 2024-05-13 and 2024-09-18 (ArgusEye, SweGaN, and FineCell on 2023-12-14), and the earliest entry dates back to 2020-12-17 (Entiros AB $6M). Sector-wise, the list is spread across Consumer Electronics (SweGaN), Biotechnology (ArgusEye), Data and Analytics (FineCell), Gaming (Lurkit), Financial Services (Medius), and Information Technology (Entiros AB), with “Other” represented once (RemaSawco). Only one row shows “Series Unknown” (ArgusEye, 2024-05-13, $3M).
Most recent rounds
7 shownRelated listings
Frequently asked
What stands out in the largest disclosed round for Linköping, and how far ahead is it of the next-largest disclosed amounts?
SweGaN’s $13M Series B on 2024-09-18 is the only disclosed round above $10M in this set, and it sits well above the next-largest disclosed amount of $3M (ArgusEye on 2024-05-13 and Lurkit on 2022-06-09).
Is there a tight timing cluster among these most recent Linköping rounds?
Yes. Two of the seven rounds in this view close in 2024—ArgusEye ($3M) on 2024-05-13 and SweGaN ($13M) on 2024-09-18—while FineCell adds another nearby datapoint with a 2023-12-14 seed of $1M.
Do any sectors appear repeatedly, or is the sector mix largely one-off?
The sector mix is largely one-off across these seven rows: Biotechnology appears once (ArgusEye), Data and Analytics once (FineCell), Gaming once (Lurkit), and Financial Services once (Medius). Consumer Electronics is also only represented once (SweGaN), and Information Technology once (Entiros AB).
How concentrated are the stages, and what’s the dominant stage type in the disclosed rounds?
Across the seven entries, Seed appears twice (FineCell $1M on 2023-12-14; Lurkit $3M on 2022-06-09), making it the most common stage label in the list. Series B appears once (SweGaN $13M on 2024-09-18), while Corporate Round (RemaSawco $150K on 2022-10-10) and Private Equity (Medius $100K on 2022-03-16) each appear once, alongside one “Series Unknown” (ArgusEye $3M on 2024-05-13).
Are there outliers by disclosed size that would warrant deeper review?
Two size outliers stand out on the downside: Medius is disclosed at $100K (2022-03-16) and RemaSawco at $150K (2022-10-10), both far below the $1M+ cluster (FineCell $1M on 2023-12-14 and ArgusEye/Lurkit at $3M). On the upside, SweGaN’s $13M (2024-09-18) is the clear high-end outlier relative to the rest of the disclosed amounts.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.